MedTrace Logo

Comparison Between External Oblique Intercostal Plane Block and the Transversus Abdominis Plane Block in Paraumbilical Hernia Repair as Analgesia for Intraoperative and Postoperative Pain.

NCT06412406 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2026-08-11

No results posted yet for this study

Summary

AIM OF STUDY:

Comparison between effect of external oblique intercostal plane block and the subcostal transversus abdominis plane block in paraumbilical hernia repair as analgesia for intraoperative and postoperative pain.

Conditions

  • Paraumbilical Hernia

Interventions

PROCEDURE

External Oblique Intercostal (EOI) block

For the external oblique intercostal plane block, patients were positioned supine. After skin disinfection and sterile preparation, a high-frequency linear ultrasound probe was used. The probe was placed in a longitudinal parasagittal orientation at the level of the ninth rib between the midclavicular and anterior axillary lines. A 21-gauge, 10-cm needle was advanced using an in-plane technique at a shallow angle until the fascial plane deep to the external oblique muscle above the ninth rib was reached. After negative aspiration, 20 mL of 0.25% bupivacaine was injected slowly on each side

PROCEDURE

Transversus abdominis plane (TAP) block

For the subcostal transversus abdominis plane block, patients were positioned supine with adequate exposure of the abdominal wall. After sterile preparation, a high-frequency linear ultrasound probe was placed below the costal margin near the midclavicular line. A 21-gauge, 10-cm needle was advanced under ultrasound guidance until the transversus abdominis plane was reached (between the rectus abdominus and transversus abdominus muscle. After negative aspiration to exclude intravascular or intraperitoneal placement, 20 mL of 0.25% bupivacaine was injected slowly on each side

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Nawal A Gadelrab, Professor · Assiut University

  • Abdelrahim M Mohamed, Professor · Assiut University

  • Mohamed G Hassan, Resident · Assiut University

  • Mohammed mamdouh mahmoud, lecterer · Assiut University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-28
Primary Completion
2025-08-10
Completion
2025-08-10

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06412406 on ClinicalTrials.gov